American Health Research

Executive Summary

American Health Research is an independent clinical research site company headquartered in Charlotte, North Carolina, founded in 2012 by Dr. Selwyn Spangenthal. The company specializes in conducting clinical trials for pharmaceutical sponsors, with a strong emphasis on patient safety, data integrity, and high-quality participant experience. Operating two sites—one in Charlotte and Clinical Research of Rock Hill in South Carolina—the firm serves as a reliable partner for Phase I–IV studies across therapeutic areas such as respiratory, internal medicine, and vaccines. Its physician-led approach and focus on community engagement help ensure robust enrollment and retention, positioning it as a preferred site for sponsors seeking efficient and compliant trial execution. As the clinical trial industry continues to rebound post-pandemic and demand for decentralized trial capabilities grows, American Health Research is well-positioned to capture new contracts by leveraging its established infrastructure and experienced staff. The company's localized presence in the Carolinas, a region with a dense biopharma footprint, provides opportunities for collaboration with mid-sized and large pharmaceutical companies. However, as a small private entity, its growth is constrained by capital availability and competition from larger site networks. Near-term outlook is stable, with potential for moderate growth through strategic partnerships and therapeutic expansion.

Upcoming Catalysts (preview)

• Q4 2026New multi-year contract with a top-20 pharma sponsor40% success
• Q2 2027Expansion into decentralized clinical trial capabilities35% success
• TBDSite acquisition or partnership to enter a new therapeutic area (e.g., oncology)20% success